Miracle Mile Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,000
| Closed | -$591K | – | 527 |
|
|
2023
Q4 | $591K | Hold |
25,000
| – | – | 0.02% | 320 |
|
|
2023
Q3 | $373K | Hold |
25,000
| – | – | 0.01% | 370 |
|
|
2023
Q2 | $274K | Hold |
25,000
| – | – | 0.01% | 430 |
|
|
2023
Q1 | $218K | Hold |
25,000
| – | – | 0.01% | 469 |
|
|
2022
Q4 | $157K | Hold |
25,000
| – | – | 0.01% | 482 |
|
|
2022
Q3 | $88K | Hold |
25,000
| – | – | ﹤0.01% | 426 |
|
|
2022
Q2 | $74K | Hold |
25,000
| – | – | ﹤0.01% | 428 |
|
|
2022
Q1 | $78K | Hold |
25,000
| – | – | ﹤0.01% | 453 |
|
|
2021
Q4 | $85K | Sell |
25,000
-25,000
| -50% | -$85K | ﹤0.01% | 440 |
|
|
2021
Q3 | $183K | Buy |
50,000
+25,000
| +100% | +$91.5K | 0.01% | 403 |
|
|
2021
Q2 | $111K | Hold |
25,000
| – | – | 0.01% | 371 |
|
|
2021
Q1 | $114K | Hold |
25,000
| – | – | 0.01% | 368 |
|
|
2020
Q4 | $144K | Hold |
25,000
| – | – | 0.01% | 357 |
|
|
2020
Q3 | $89K | Hold |
25,000
| – | – | 0.01% | 344 |
|
|
2020
Q2 | $87K | Hold |
25,000
| – | – | 0.01% | 300 |
|
|
2020
Q1 | $37K | Hold |
25,000
| – | – | ﹤0.01% | 270 |
|
|
2019
Q4 | $49K | Buy |
+25,000
| New | +$49K | ﹤0.01% | 295 |
|